Ditto, the Rotterdam-based patient-facing healthcare AI app, has raised €7.6 million to fund its European rollout. The round is led by Heal Capital, with participation from Optiverder and Rubio Impact Ventures. The company won the 2026 Dutch National Healthcare Innovation Award and has been recommended to all policyholders by health insurer Menzis.
The app addresses a structural gap in the patient experience: consultations are brief, and when difficult news is delivered, patients frequently leave without retaining what was said. Ditto allows patients to record a consultation or photograph a letter from their doctor, generating a clear summary within minutes that can be translated into English, Turkish, or Arabic and shared securely with family, with no central data storage. Nearly 100,000 people have downloaded the app since its launch in summer 2025, and the Dutch Patients’ Federation has embraced the initiative. The funding will go toward European expansion and new features, including pre-consultation question guides and a visual care journey tool for patients and their families.
Ditto was founded by Tobias Polak, who holds a PhD in biostatistics and previously worked at Erasmus MC and myTomorrows; Bart Voorn, a former Head of R&D AI and Robotics at Ahold Delhaize; and Merlijn van Breugel, a PhD candidate in AI and pediatric lung diseases and former Lead Data Scientist at Rewire.
KEY QUOTES:
“We are fundamentally turning the thinking in healthcare around: starting not with the institution, but with the patient. Our ambition is for all Europeans to better understand their care journey at the most vulnerable moments in life.”
Tobias Polak, Co-Founder, Ditto
“Ditto builds the equivalent for patients, and its traction proves they have hit a nerve. We believe this will become the European platform for how people navigate their care.”
Dr. Lucas Mittelmeier, Heal Capital
